IGF-1 LR3 Product Brief

Ready-to-Sell Research Product Sheet

1. Compound Overview

IGF-1 LR3 (Long R3 Insulin-Like Growth Factor-1) is a modified analog of human insulin-like growth factor-1 designed for extended activity.
It contains an arginine substitution at position 3 and an additional 13-amino-acid extension, which reduces binding to IGF-binding proteins and prolongs its half-life.

IGF-1 LR3 is widely studied in research exploring cellular growth signaling, muscle tissue development, and regenerative biological pathways.

2. Mechanism of Interest

IGF-1 LR3 is studied for several biological mechanisms:

• Activation of the IGF-1 receptor (IGF-1R)
  • Stimulation of cellular growth and proliferation pathways
  • Increased protein synthesis signaling
  • Potential influence on muscle cell hypertrophy pathways
  • Interaction with growth hormone and endocrine signaling networks

3. Research Areas Being Explored

• Muscle growth and regeneration studies
  • Cellular proliferation and signaling pathways
  • Metabolic signaling research
  • Tissue repair and regeneration models
  • Growth hormone axis research

4. Suggested Research Vial Sizes

• 1 mg lyophilized vial
  • 2 mg lyophilized vial
  • 5 mg research vial
  • 10 mg laboratory vial

5. Example Reconstitution Chart

Example mixing protocols commonly used in research contexts:

1 mg vial + 1 mL bacteriostatic water = 1 mg/mL concentration

2 mg vial + 2 mL bacteriostatic water = 1 mg/mL concentration

5 mg vial + 2 mL bacteriostatic water = 2.5 mg/mL concentration

These concentrations allow precise measurement in laboratory research environments.

6. Label Information for Vials

• Compound name: IGF-1 LR3
  • Total amount per vial (mg)
  • Lot / batch number
  • Manufacturing date
  • Storage instructions (2–8°C recommended before reconstitution)
  • Research use only disclaimer

7. Market Positioning

IGF-1 LR3 is commonly positioned in the growth factor and regenerative research peptide category.

It is frequently associated with research exploring:

• Muscle tissue growth models
  • Cellular proliferation pathways
  • Recovery and regeneration studies
  • Growth hormone axis signaling research

8. Example Research Stack Categories

• IGF-1 LR3 + CJC-1295 / Ipamorelin
  • IGF-1 LR3 + BPC-157
  • IGF-1 LR3 + TB-500
  • IGF-1 LR3 + Growth hormone related peptides

9. Safety and Regulatory Notes

IGF-1 LR3 is not approved by the FDA for medical treatment and is commonly distributed as a research compound.

This document is intended for informational and research product description purposes only.